New Customers - Genitope
Current Customers | New Customers
Genitope is a biotech company specializing in research and development of novel personalized immunotherapies for the treatment of cancer, recently chose the MasterControl integrated quality management suite to assist with the management of their quality documentation. Genitope's lead product, MyVax® Personalized Immunotherapy, is currently in pivotal Phase 3 clinical trials for the treatment of follicular non-Hodgkin's lymphoma (f-NHL). Genitope will be implementing MasterControl Documents, MasterControl Forms, and MasterControl Training to assist with the management of its quality processes.
|
Watch Videos |
Share This Article
7 Mar
MasterControl Announces Release of Clinical Suite Offering
5 Mar
MasterControl's Marcus and Murray at MD&M Texas
31 Jan
MasterControl Reports Strong Fourth Quarter and Annual Sales
25 Oct
MasterControl Releases EDM Jump Start Reference Model
17 Oct
MasterControl, Inc. Named to Software Magazine's 29th Annual Software 500
21 Sep
MasterControl, Inc. Named to the 2011 Inc. 500|5000
9 Sep
MasterControl Version 10.0 Release
2 Jun
MasterControl and Japanese Automation Leader Yamatake Announce Partnership












